4263 — Susmed Balance Sheet
0.000.00%
- ¥9bn
- ¥5bn
- ¥343m
Annual balance sheet for Susmed, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 366 | 1,627 | 4,904 | 5,049 | 4,847 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.52 | 17.2 | 9.57 | 10.9 | 20.2 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 379 | 1,675 | 4,936 | 5,085 | 4,898 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 382 | 1,675 | 4,944 | 5,101 | 4,932 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 22.7 | 96.3 | 87.7 | 225 | 321 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 26.4 | 97.2 | 93.3 | 230 | 328 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 355 | 1,578 | 4,850 | 4,871 | 4,604 |
Total Liabilities & Shareholders' Equity | 382 | 1,675 | 4,944 | 5,101 | 4,932 |
Total Common Shares Outstanding |